Clinical Trial Update: Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of vildagliptin in patients with renal impairment completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis | Conditions: Type-2 Diabetes | Phase 1 | Status: COMPLETED